Market Price

15.06 

0.06 0.4%

as of Aug 18 '19

52 Week Range:

11.32 16.19


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems. It provides its products for use in respiratory care, acute care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and within the hospital. The company offers adult respiratory products, including AIRVO 2 system, a humidifier with integrated flow source; Optiflow, a nasal high flow therapy; and noninvasive and invasive ventilation systems. It also provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, accessories, and interfaces; and homecare products that include masks, CPAP devices, data management products, humidifiers, and accessories. It has operations in North America, Europe, the Asia Pacific, and internationally. The company was founded in 1934 and is headquartered in Auckland, New Zealand.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19
Equity (BVPS) 0.33
0.44
0.44
0.46
0.52
0.60
0.66
0.72
0.99
1.11
1.24
growth rate 33.3% 0.0% 4.6% 13.0% 15.4% 10.0% 9.1% 37.5% 12.1% 11.7%
Earnings BIT 70.31
82.77
68.25
72.75
113.00
143.50
170.08
211.08
240.10
269.80
292.60
growth rate 17.7% -17.5% 6.6% 55.3% 27.0% 18.5% 24.1% 13.8% 12.4% 8.5%
Avg.PE 26.67
24.27
32.05
19.05
18.98
24.45
45.33
62.91
49.11
57.43
64.49
growth rate -9.0% 32.1% -40.6% -0.4% 28.8% 85.4% 38.8% -21.9% 16.9% 12.3%
ROA 16.36
15.63
10.31
12.15
13.05
16.74
17.79
19.17
20.70
20.25
18.91
growth rate -4.5% -34.0% 17.9% 7.4% 28.3% 6.3% 7.8% 8.0% -2.2% -6.6%
ROE 30.43
28.03
16.87
20.01
21.58
26.79
26.33
27.20
28.29
27.08
25.20
growth rate -7.9% -39.8% 18.6% 7.9% 24.1% -1.7% 3.3% 4.0% -4.3% -6.9%
ROIC 24.17
20.27
13.84
15.79
16.72
21.61
23.55
25.35
25.98
24.79
23.01
growth rate -16.1% -31.7% 14.1% 5.9% 29.3% 9.0% 7.6% 2.5% -4.6% -7.2%
Cur. Ratio 1.84
1.84
2.22
1.29
2.36
1.82
2.08
1.91
2.40
2.38
2.47
growth rate 0.0% 20.7% -41.9% 83.0% -22.9% 14.3% -8.2% 25.7% -0.8% 3.8%
Quick Ratio 0.92
0.80
1.02
0.55
0.98
0.81
1.03
1.00
1.31
1.56
1.62
growth rate -13.0% 27.5% -46.1% 78.2% -17.4% 27.2% -2.9% 31.0% 19.1% 3.9%
Leverage 2.03
1.62
1.65
1.64
1.66
1.55
1.42
1.42
1.33
1.35
1.32
growth rate -20.2% 1.9% -0.6% 1.2% -6.6% -8.4% 0.0% -6.3% 1.5% -2.2%
Balance Sheet Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19
Acct.Receivable 1.50
1.30
80.00
78.00
83.00
94.71
109.29
133.24
131.60
147.70
159.30
growth rate -13.3% 6,053.9% -2.5% 6.4% 14.1% 15.4% 21.9% -1.2% 12.2% 7.9%
Acct.Payable 21.00
23.00
21.00
23.22
27.66
36.96
29.30
32.70
55.10
growth rate 9.5% -8.7% 10.6% 19.1% 33.6% -20.7% 11.6% 68.5%
Cur.Assets 142.80
139.50
186.00
195.00
215.00
234.96
243.29
285.72
349.10
424.20
455.30
growth rate -2.3% 33.3% 4.8% 10.3% 9.3% 3.6% 17.4% 22.2% 21.5% 7.3%
Total Assets 342.10
368.10
518.00
572.00
619.00
630.33
669.82
766.80
878.20
1,025.10
1,206.70
growth rate 7.6% 40.7% 10.4% 8.2% 1.8% 6.3% 14.5% 14.5% 16.7% 17.7%
Cash 4.50
5.30
6.00
6.00
8.00
10.44
13.62
18.74
61.30
31.90
48.20
growth rate 17.8% 13.2% 0.0% 33.3% 30.5% 30.5% 37.6% 227.1% -48.0% 51.1%
Inventory 57.80
55.60
80.00
84.00
89.00
94.48
96.14
120.95
135.00
125.40
136.10
growth rate -3.8% 43.9% 5.0% 6.0% 6.2% 1.8% 25.8% 11.6% -7.1% 8.5%
Cur.Liabilities 77.60
75.80
84.00
151.00
91.00
128.79
117.11
149.52
145.60
178.40
184.40
growth rate -2.3% 10.8% 79.8% -39.7% 41.5% -9.1% 27.7% -2.6% 22.5% 3.4%
Liabilities 173.20
140.90
204.00
224.00
246.00
224.20
198.63
225.13
216.60
263.70
293.50
growth rate -18.7% 44.8% 9.8% 9.8% -8.9% -11.4% 13.4% -3.8% 21.8% 11.3%
LT Debt 80.60
46.20
85.00
40.00
123.00
66.08
55.40
50.82
40.30
52.70
69.30
growth rate -42.7% 84.0% -52.9% 207.5% -46.3% -16.2% -8.3% -20.7% 30.8% 31.5%
Equity 168.90
227.20
230.40
274.40
298.60
406.12
471.19
541.67
661.60
761.40
913.20
growth rate 34.5% 1.4% 19.1% 8.8% 36.0% 16.0% 15.0% 22.1% 15.1% 19.9%
Common Shares 527.00
531.00
535.00
548.00
558.00
558.00
569.00
571.00
573.00
576.00
578.00
growth rate 0.8% 0.8% 2.4% 1.8% 0.0% 2.0% 0.4% 0.4% 0.5% 0.4%
Cash Flow Statement Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19
Capital Expenditures 16.80
35.40
41.00
65.00
59.00
27.31
39.27
48.02
47.90
83.20
115.40
growth rate 110.7% 15.8% 58.5% -9.2% -53.7% 43.8% 22.3% -0.2% 73.7% 38.7%
Cash Dividends 54.80
52.80
50.50
55.30
57.00
36.14
42.81
61.20
79.90
91.80
101.00
growth rate -3.7% -4.4% 9.5% 3.1% -36.6% 18.5% 42.9% 30.6% 14.9% 10.0%
Cash From OA 51.30
106.50
71.00
94.00
86.00
99.50
146.83
144.57
193.60
247.80
253.30
growth rate 107.6% -33.3% 32.4% -8.5% 15.7% 47.6% -1.5% 33.9% 28.0% 2.2%
FCF per Share 0.06
0.13
0.04
0.06
0.04
0.07
0.15
0.11
0.20
0.18
0.25
growth rate 116.7% -69.2% 50.0% -33.3% 75.0% 114.3% -26.7% 81.8% -10.0% 38.9%
Sale Purchase of Stock 0.65
2.11
1.57
1.60
1.80
growth rate 222.5% -25.6% 1.9% 12.5%
FCF 33.00
69.00
20.00
21.00
20.00
68.00
91.00
71.00
119.00
140.00
115.00
growth rate 109.1% -71.0% 5.0% -4.8% 240.0% 33.8% -22.0% 67.6% 17.7% -17.9%
Income Statement Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19
Sales 401.50
367.90
506.00
517.00
556.00
623.45
672.35
815.49
894.40
980.80
1,070.40
growth rate -8.4% 37.5% 2.2% 7.5% 12.1% 7.8% 21.3% 9.7% 9.7% 9.1%
Op.Income 104.30
54.20
52.00
64.00
113.00
143.50
170.08
211.08
240.10
269.80
292.60
growth rate -48.0% -4.1% 23.1% 76.6% 27.0% 18.5% 24.1% 13.8% 12.4% 8.5%
IBT 70.30
82.80
68.20
72.70
87.80
136.66
158.77
200.83
238.50
267.80
291.20
growth rate 17.8% -17.6% 6.6% 20.8% 55.7% 16.2% 26.5% 18.8% 12.3% 8.7%
Net Income 51.50
55.50
52.00
64.00
77.00
97.05
113.17
143.43
169.20
190.20
209.20
growth rate 7.8% -6.3% 23.1% 20.3% 26.0% 16.6% 26.7% 18.0% 12.4% 10.0%
EPS 0.10
0.10
0.07
0.09
0.11
0.16
0.20
0.23
0.27
0.31
0.35
growth rate 0.0% -30.0% 28.6% 22.2% 45.5% 25.0% 15.0% 17.4% 14.8% 12.9%
Gross Profit 226.10
187.50
278.00
275.00
308.00
365.40
410.98
521.65
590.40
650.40
715.80
growth rate -17.1% 48.3% -1.1% 12.0% 18.6% 12.5% 26.9% 13.2% 10.2% 10.1%
R&D 23.40
27.30
28.90
33.10
36.70
54.15
64.99
73.29
86.00
94.70
100.40
growth rate 16.7% 5.9% 14.5% 10.9% 47.5% 20.0% 12.8% 17.4% 10.1% 6.0%

Quarterly Statements

Item Name Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Earnings BIT 77.40
69.50
69.50
76.80
76.80
growth rate -10.2% 0.0% 10.5% 0.0%
Balance Sheet Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Acct.Receivable 147.70
153.00
153.00
159.30
159.30
growth rate 3.6% 0.0% 4.1% 0.0%
Acct.Payable 32.70
114.80
114.80
55.10
55.10
growth rate 251.1% 0.0% -52.0% 0.0%
Cur.Assets 424.20
406.40
406.40
455.30
455.30
growth rate -4.2% 0.0% 12.0% 0.0%
Total Assets 1,025.10
1,044.00
1,044.00
1,206.70
1,206.70
growth rate 1.8% 0.0% 15.6% 0.0%
Cash 31.90
55.50
55.50
48.20
48.20
growth rate 74.0% 0.0% -13.2% 0.0%
Inventory 125.40
135.40
135.40
136.10
136.10
growth rate 8.0% 0.0% 0.5% 0.0%
Cur.Liabilities 178.40
195.50
195.50
184.40
184.40
growth rate 9.6% 0.0% -5.7% 0.0%
Liabilities 263.70
267.30
267.30
293.50
293.50
growth rate 1.4% 0.0% 9.8% 0.0%
LT Debt 52.70
45.30
45.30
69.30
69.30
growth rate -14.0% 0.0% 53.0% 0.0%
Equity 761.40
776.70
776.70
913.20
913.20
growth rate 2.0% 0.0% 17.6% 0.0%
Common Shares 201.40
213.30
213.30
221.00
221.00
growth rate 5.9% 0.0% 3.6% 0.0%
Cash Flow Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Capital Expenditures 19.55
26.85
26.85
30.85
30.85
growth rate 37.3% 0.0% 14.9% 0.0%
Cash Dividends 17.00
31.70
31.70
18.80
18.80
growth rate 86.5% 0.0% -40.7% 0.0%
Cash From OA 82.80
46.70
46.70
79.95
79.95
growth rate -43.6% 0.0% 71.2% 0.0%
Sale Purchase of Stock 0.65
growth rate
FCF 63.25
19.85
19.85
49.10
49.10
growth rate -68.6% 0.0% 147.4% 0.0%
Income Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Sales 261.20
255.65
255.65
279.55
279.55
growth rate -2.1% 0.0% 9.4% 0.0%
Op.Income 77.40
69.50
69.50
76.80
76.80
growth rate -10.2% 0.0% 10.5% 0.0%
IBT 76.85
67.95
67.95
77.65
77.65
growth rate -11.6% 0.0% 14.3% 0.0%
Net Income 54.45
48.70
48.70
55.90
55.90
growth rate -10.6% 0.0% 14.8% 0.0%
Gross Profit 173.85
170.80
170.80
187.10
187.10
growth rate -1.8% 0.0% 9.5% 0.0%
R&D 23.90
22.85
22.85
27.35
27.35
growth rate -4.4% 0.0% 19.7% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A (88.39)

YOY Growth Grade:

B (69.14)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 62.37 61.47 43.66
EPS / Growth 21.9% 0.25 13.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 18.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 13.2% 17.9% 17.9%
Future PE 26.40 47.26 47.26
Future EPS 0.85 1.27 1.27
Value Price
MOS %
5.52
-63.3%
14.83
-1.5%
14.83
-1.5%
MOS Price 2.76 7.41 7.41
IRT 16.94 14.18 14.18

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.